Back
Madrigal Pharmaceuticals Vs. DXP Enterprises Industry Stock Comparison
Buy
68
MDGL
Madrigal Pharmaceuticals
Last Price:
338.08
Seasonality Move:
34.75%
Buy
69
DXPE
DXP Enterprises
Last Price:
65.85
Seasonality Move:
39.89%
Buy
68
Madrigal Pharmaceuticals (MDGL)
is a Buy
Is Madrigal Pharmaceuticals a Buy, Sell or Hold?
- The current Madrigal Pharmaceuticals [MDGL] share price is $338.31. The Score for MDGL is 68, which is 36% above its historic median score of 50, and infers lower risk than normal.
- MDGL is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
69
DXP Enterprises (DXPE)
is a Buy
Is DXP Enterprises a Buy, Sell or Hold?
- The current DXP Enterprises [DXPE] share price is $65.59. The Score for DXPE is 69, which is 38% above its historic median score of 50, and infers lower risk than normal.
- DXPE is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
MDGL Stock Price Chart
What is Madrigal Pharmaceuticals's stock price today?
-
The Madrigal Pharmaceuticals share price today is $338.31
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and MDGL is experiencing slight buying pressure.
DXPE Stock Price Chart
What is DXP Enterprises's stock price today?
-
The DXP Enterprises share price today is $65.59
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and DXPE is experiencing buying pressure, which is a positive indicator for future bullish movement.
MDGL Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 25.67 | Buy |
| Relative Strength Index (14 RSI): | 87.36 | Buy |
| Chaikin Money Flow: | 121357 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (188.29 - 277.25) | Buy |
| Bollinger Bands (100): | (220.14 - 283.54) | Buy |
DXPE Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 1.43 | Buy |
| Relative Strength Index (14 RSI): | 80.07 | Buy |
| Chaikin Money Flow: | 113745 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (48.39 - 56.11) | Buy |
| Bollinger Bands (100): | (46.95 - 53.81) | Buy |
MDGL Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 279.61 | Buy |
| 20-day SMA: | 238.15 | Buy |
| 50-day SMA: | 233.3 | Buy |
| 200-day SMA: | 242.73 | Buy |
| 8-day EMA: | 293.17 | Buy |
| 20-day EMA: | 256.05 | Buy |
| 50-day EMA: | 242 | Buy |
| 200-day EMA: | 237.48 | Buy |
DXPE Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 53.29 | Buy |
| 20-day SMA: | 52.29 | Buy |
| 50-day SMA: | 52.04 | Buy |
| 200-day SMA: | 47.99 | Buy |
| 8-day EMA: | 55.52 | Buy |
| 20-day EMA: | 53.02 | Buy |
| 50-day EMA: | 51.94 | Buy |
| 200-day EMA: | 47.55 | Buy |
Madrigal Pharmaceuticals Earnings Growth & MDGL Earnings Dates
- Analysts estimate an earnings decrease this quarter of $4.11 per share, a decrease next quarter of $0.00 per share, a decrease this year of $4.14 per share, and an increase next year of $9.75 per share.
DXP Enterprises Earnings Growth & DXPE Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.11 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.24 per share, and an increase next year of $0.30 per share.
Madrigal Pharmaceuticals Technical Analysis
| Oct 24 | Oct 25 | Oct 28 | Oct 29 | Oct 30 | Oct 31 | Nov 1 | Nov 4 | Nov 5 | Nov 6 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | Nov | |||||||||
| 24 | 25 | 28 | 29 | 30 | 31 | 01 | 04 | 05 | 06 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
DXP Enterprises Technical Analysis
| Oct 24 | Oct 25 | Oct 28 | Oct 29 | Oct 30 | Oct 31 | Nov 1 | Nov 4 | Nov 5 | Nov 6 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | Nov | |||||||||
| 24 | 25 | 28 | 29 | 30 | 31 | 01 | 04 | 05 | 06 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||